Effection of NP concurrent chemotherapy radiotherapy and sequential adoptive immunity cell for locally advanced non-small cell lung cancer

Chinese Journal of Cancer Prevention and Treatment

Volumn 18, Issue 13, 2011, Pages 1032-1035

  Xu, Yong Mao ^a   Xu, Dong Yun ^a   Zhang, Nan Zheng ^a   Chen, Fu Xing ^a   Zhang, Guo Long ^a   Liu, Jun Quan ^a   Li, Chun Yan ^a  

^a No 97 Hospital of PLA   (China)

Author keywords

Adoptive immunity cell; Carcinoma, non small cell lung drug therapy; Carcinoma, non small cell lung radiotherapy; Combined modality therapy; Comparative study

Indexed keywords

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CELLULAR IMMUNITY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE INDUCED KILLER CELL; DENDRITIC CELL; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 84855391752     PISSN: 16735269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Curran W J, Scott C B, Langer C J, et al. Long-term benefit is observed in a Phase III comparison of sequential vs concurrent chemo-radiation in patients with unresected stage III NSCLC: RTOG 9410[J]. Proc Am Soc Clin Oncol, 2003, 22:821.
2. Chen T F, Jiang G L, Fu X L, et al. Prognostic significance of CK19 mRhiA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in peripheral blood of patients with non-small cell lung cancers treated by chemo-radiation[J]. Int J Radiat Oncol Biol Phys, 2004, 60(Supp 1):237.
3. Ara A V, Merrins K, Craig W, et al. Cancer medicine 6[M]. An Approved Publication of The American Cancer Society, 2003, 27(92):1385-1445.
4. Wan F S, Liu M X, Zhang B, et al. antitumor activities of human autologous cytoine-induced killer (CIK) cells against hepatocellular carcinoma cells in vitro and in vivo[J]. Word J Gastroenterol, 2002, 8(3):464-468. (Pubitemid 34692743)
5. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells[J]. Annu Rev Immunol, 2000, 18:767-811. (Pubitemid 30365397)
6. Schott M, Seissler J. Dendritic cell vaccination: new hope for treatment of metastasized endocrine malignancies[J]. Trends Endocrinol Metab, 2003, 14(4):156-162. (Pubitemid 36733900)
7. Mullins D W, Sheasley S L, Ream R M, et al. Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control[J]. J Exp Med, 2003, 198(7):1023-1034. (Pubitemid 37248618)
8. Hernberg W, Muhonen T, Turunen T P, et al. The CD4/CD8 ratio as a prognostic in patients with metastic melanoma receiving chemoimmunotherapy[J]. J of clinical oncology, 1996, 14(5):1690-1696. (Pubitemid 26134228)
9. Scki S, Habu Y, Kawamura T, et al. The liver as a crucial organ in the first line of host defense: the roles of kupffer cells, natural killer cells and NK1.1Ag+ T cells in T helper immune eesponses[J]. Immunological Rev, 2000, 174(1):35-46. (Pubitemid 30201377)